Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)

Completed · Phase 3

Conditions studied: Rhinitis, Allergic, Seasonal

In brief

Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Commonly referred to as (hay fever), it is characterized by sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes. The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with seasonal allergic rhinitis (SAR) caused by ragweed pollen.

Key facts

Study ID

NCT00197262

Run by

GlaxoSmithKline

People needed

288

Starts

2005-08-01

Expected to finish

2005-10-01

Last updated by the study team

2017-01-19

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be outpatients.
• Diagnosis of SAR.
• Literate in English or native language.

You may not qualify if…

• Have a significant concomitant medical condition.
• Use corticosteroids or other allergy medications during the study.
• Use tobacco products.

Where it is running

• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — Indianapolis, Indiana, United States
• GSK Investigational Site — Lafayette, Indiana, United States
• GSK Investigational Site — Louisville, Kentucky, United States
• GSK Investigational Site — Novi, Michigan, United States
• GSK Investigational Site — Minneapolis, Minnesota, United States
• GSK Investigational Site — Columbia, Missouri, United States
• GSK Investigational Site — Rolla, Missouri, United States
• GSK Investigational Site — St Louis, Missouri, United States
• GSK Investigational Site — Lincoln, Nebraska, United States
• GSK Investigational Site — Papillion, Nebraska, United States
• GSK Investigational Site — Canton, Ohio, United States
• GSK Investigational Site — Sylvania, Ohio, United States
• GSK Investigational Site — Spartanburg, South Carolina, United States
• GSK Investigational Site — Dallas, Texas, United States
• GSK Investigational Site — Dallas, Texas, United States
• GSK Investigational Site — Greenfield, Wisconsin, United States
• GSK Investigational Site — West Allis, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.